Stock picks from our team of market veterans.
Hedge funds and other short sellers have had a picnic dumping any stock where AI could possibly threaten the underlying business. But are we seeing a hijacking of great businesses by market 'terrorists' that we could make money out of?
Are bad times behind this leading global biotechnology company founded in Australia in 1916?
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans maintains its BUY rating for Breville Group (BRG).
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.
For the week ending Friday, February 13, 2026, FNArena tracked 31 upgrades and 12 downgrades for ASX-listed companies from brokers monitored daily.
While Artificial Intelligence fears may drive software-as-a-service stocks below their real worth, index investing can still play a role.
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains in more detail why he believes that ORI is just undergoing a healthy consolidation and is ready to move higher again.
Here are three stocks positioned nicely to bring gas to hungry markets. These are unprofitable, speculative stocks – with attractive potential attributes – so, as always, do your own homework!
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.
Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re concerned you might have too much exposure to them, here are some index tracking ETFs to consider.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.